Pfizer-BioNTech has transmitted the results of clinical tests conducted with the vaccine they produce on children between 5 and 11 years to the EMA in order to obtain the green light for its use.
This was announced by the same company.
Currently, no vaccines have been authorized in Europe for this age group.